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DNA Methylation Patterns in Cord Blood of
Neonates Across Gestational Age
Association With Cell-Type Proportions

Susan M. Braid ▼ Kwame Okrah ▼ Amol Shetty ▼ Hector Corrada Bravo

Background: A statistical methodology is available to estimate the proportion of cell types (cellular heterogeneity) in adult whole
blood specimens used in epigenome-wide association studies (EWAS). However, there is no methodology to estimate the
proportion of cell types in umbilical cord blood (also a heterogeneous tissue) used in EWAS.
Objectives: The objectives of this study were to determine whether differences in DNA methylation (DNAm) patterns in umbilical
cord blood are the result of blood cell type proportion changes that typically occur across gestational age and to demonstrate the
effect of cell type proportion confounding by comparing preterm infants exposed and not exposed to antenatal steroids.
Methods: We obtained DNAm profiles of cord blood using the Illumina HumanMethylation27k BeadChip array for 385 neonates
from the Boston Birth Cohort. We estimated cell type proportions for six cell types using the deconvolution method developed by
Houseman et al. (2012).
Results: The cell type proportion estimates segregated into two groups that were significantly different by gestational age,
indicating that gestational age was associated with cell type proportion. Among infants exposed to antenatal steroids, the
number of differentially methylated CpGs dropped from 127 to 1 after controlling for cell type proportion.
Discussion: EWAS utilizing cord blood are confounded by cell type proportion. Careful study design including correction for cell
type proportion and interpretation of results of EWAS using cord blood are critical.
Key Words: Boston Birth Cohort  cell type proportion  DNA methylation  epigenomics  gestational age  neonates 
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pigenome-wide association studies (EWAS) are increasingly being used to investigate birth weight,
prematurity, and exposures in neonates with the
hope of providing insight into molecular differences so that
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interventions can be developed. These studies utilize umbilical
cord blood to measure DNA methylation (DNAm; Chen et al.,
2014; Kile et al., 2014; Lee et al., 2012; Liu et al., 2014; Remy
et al., 2014), but most of these studies do not take into account
the fact that umbilical cord blood, like adult blood, is a heterogeneous tissue (Blackburn, 2013). For example, the proportion of leukocytes can vary depending on age, disease status,
and other variables that impact the immune system. This
means that any DNAm differences may be confounded by differences in the cellular proportions of the umbilical cord
blood samples because EWAS may yield associations that are
false positives; that is, findings may be the result of cell type
proportion differences rather than an exposure of interest. Researchers have recognized that cellular heterogeneity is a significant issue for EWAS utilizing adult whole blood specimens,
developed specialized statistical methods to account for that
heterogeneity, and adapted those methods as tools for epigenetic research continue to evolve (Jaffe & Irizarry, 2014).
In a seminal paper, Houseman et al. (2012) developed
an algorithm to estimate the proportion of immune cells
www.nursingresearchonline.com
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in adult whole blood by identifying differentially methylated DNA regions (DMRs) for each of the principal immune
components of whole blood—granulocytes, monocytes,
and some subpopulations of lymphocytes (CD4 T cells, CD8
T cells, natural killer [NK] cells, and B cells). Using the Illumina
HumanMethylation27k BeadChip Microarray (Illumina, Inc.,
San Diego, CA), the authors identified 500 CpG sites that are
specific to these cell types and provided new analytical
tools for estimating cell type proportions in EWAS. Despite
the availability of this algorithm, few researchers have attempted to address potential confounding from cell type heterogeneity in their EWAS analyses in umbilical cord blood.
Three research teams have used the methodology created by Houseman et al. (2012) to examine the impact of
exposures and DNAm while controlling for blood cell type
proportions in cord blood. Most recently, the methodology
was used to demonstrate that in utero arsenic exposure in
term and preterm infants was associated with altered
DNAm patterns after controlling for leukocyte proportions;
in utero arsenic exposure had a dose-dependent effect on
certain T-cell subpopulations in umbilical cord blood (Kile
et al., 2014). A similar approach was used when studying
DNAm patterns and birth weight in both term and preterm
infants (Engel et al., 2014). Deconvolution analysis was also
used to infer changes in the distribution of leukocytes in a
study of arsenic exposure in utero and cord blood DNAm
in term infants (Koestler, Avissar-Whiting, Houseman,
Karagas, & Marsit, 2013). These research teams all used
the methodology created by Houseman et al. (2012), including the reference data set comprising only adult peripheral blood samples; several noted that it is unclear whether
this methodology is sufficient for correcting the cellspecific patterns of DNAm in umbilical cord blood.
The methodology developed by Houseman et al. (2012)
may not be sufficient for leukocyte proportion adjustment
when analyzing cord blood because blood cell type proportion
changes naturally across gestational age. DNAm levels are measured on nucleated cells, and in cord blood, most of the cells
with nuclei are the cells of the immune system (i.e., monocytes neutrophils, eosinophils, basophils, B cells, NK cells,
and T cells). Because immunological changes occur in gestation, cord blood cell type proportions fluctuate greatly throughout fetal development and may vary significantly depending
on the gestational age of the infant (Koenig & Yoder, 2004;
Maheshwari & Christensen, 2004; Segel & Palis, 1995; Ygberg
& Nilsson, 2012). Granulocytes (Remington, Klein, Wilson,
Nizet, & Maldonado, 2001), CD4 T cells (Chabra et al., 1998;
Duijts et al., 2009), and B cells (Correa-Rocha et al. 2012;
Thilaganathan, Nicolaides, Mansur, Levinsky, & Morgan, 1993)
increase during gestation, whereas NK cells vary throughout
gestation (Correa-Rocha et al., 2012; Pérez, Gurbindo, Resino,
Aguarón, & Muñoz-Fernández, 2007; Peoples et al., 2009;
Ygberg & Nilsson, 2012). If cord blood cell type proportion
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differences between samples account for a certain amount
of the overall DNAm variability, then cell type proportion fluctuations across gestational age should significantly affect
DNAm findings.
As researchers continue to analyze the impact of environmental exposures on the fetal epigenome by studying cord
blood, it is critical that we clarify whether cell type proportion
is confounding findings. We hypothesize that researchers analyzing the DNAm of cord blood without correction for cell
type proportions will identify differentially methylated CpGs,
which they may attribute to an environmental exposure, when
in fact, those differences between DNAm patterns may exist
only because of cell type proportion changes across gestational
age. Therefore, the objective of this study was to determine
whether differences in DNAm patterns in umbilical cord blood
are the result of blood cell type proportion changes that occur
naturally across gestational age and to highlight the potential
for confounded results by comparing a sample of preterm infants who were exposed and not exposed to antenatal steroids.
In this study, we used Houseman et al.’s (2012) deconvolution methodology to analyze the DNAm profiles of
cord blood for 385 term and preterm infants from the Boston
Birth Cohort, ranging from 30 to 44 weeks in gestational
age. The aims were to:
1. measure the amount of overall DNAm variability that may be
accounted for by differences in cell type proportions in the
umbilical cord blood of term and preterm infants, relative to
differences in gestational age and gender;
2. estimate cell type proportions for six cell types (granulocytes,
monocytes, B cells, NK cells, CD4 T cells, and CD8 T cells)
and identify differences in cell type proportion patterns across
gestational age; and
3. determine if an analysis of the cord blood of preterm infants
(gestational ages 30–36 weeks) exposed and not exposed to
antenatal steroids reveals differences in DNAm patterns and
whether some or all of those patterns can be explained by differences in cell type proportions as an illustrative example of
potential confounding.

Glucocorticosteroids are a common exposure in preterm infants, and yet, research indicates that steroid application is associated with changes in DNAm (Carreno
et al., 2011; Romero, Dey, & Fisher, 2014). The question
is whether controlling for cell type proportions would impact this finding. As far as we are aware, this is the first
study to use the DMRs identified by Houseman et al.
(2012) to investigate how umbilical cord blood cell type
proportion changes over gestation.

METHODS
Study Sample
The sample for this study was taken from an ongoing study called
the Boston Birth Cohort (BBC) that enrolls mother–infant
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pairs from Boston Medical Center at birth and follows them
prospectively. We studied a subsample of 385 African
American, Haitian, or Cape Verdean mother–infant pairs; gestational ages ranged from 25 and 44 weeks. Cord blood was
collected from all births at the time of delivery by trained nursing staff. Maternal interviews were conducted using a structured questionnaire. Gestational age was assessed with an
algorithm based on the last menstrual period and early ultra
sound before 20 weeks gestation. Further details concerning BBC design and methodology are available in D. Wang
et al. (2012) and X. Wang et al. (2002).
Maternal consent was obtained for all cohort participants.
The BBC was approved by the Boston Medical Center and
Johns Hopkins University Institutional Review Boards. This
study was approved by the University of Maryland Institutional Review Board.

DNAm Data Preprocessing
We obtained DNAm profiles of cord blood using the Illumina
HumanMethylation27k BeadChip (Illumina, Inc.) array for
385 neonates from the BBC. Only probes in autosomes were
used to avoid bias from large differences in sex chromosomes.
Arrays with low total signal were filtered as part of quality assessment. We detected a strong batch effect for one of the
27k arrays and removed samples from that array. We restricted
samples to those over 30 weeks of gestational age because only
six samples were less than 30 weeks. After filtering the cord
blood samples for total signal and batch correction, we
dropped 38 samples, including some from infants born at later
gestational ages because of quality assurance issues; we
retained 341 samples, ranging from 30 to 43 weeks gestational
age. Methylated and unmethylated signals were each quantile
normalized across arrays using a modification of the minfi
package (Aryee et al., 2014). We used the Illumina-provided
annotation for the 27k BeadArray (HumanMethylation27
270596 v.1.2.bpm). All analyses were performed on methylation percentages computed after quantile normalization—
except where noted.

Blood Cell Type-Specific CpGs
We obtained the top 500 CpGs for the 27k array that distinguish
cell types in adult blood as described in Houseman et al. (2012)
and implemented in code provided by that group using version
112 (http://people.oregonstate.edu/~housemae/software/).

Hierarchical Clustering
We performed hierarchical clustering analysis using Euclidean
distance on methylation log ratio (M values) and estimated cell
type estimates. Using both a two-sided t-test with unequal variance and a Wilcoxon rank-sum test, we completed tests for
difference in gestational age across clusters, segregating samples according to the first partition obtained by hierarchical
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clustering. Tests for difference in variance on these two
groups of samples were performed using an F-test.

Cell Type Proportion Estimation
We estimated cell type proportions for six cell types
(granulocytes, monocytes, B cells, NK cells, CD4 T cells, and
CD8 T cells) using Houseman et al.’s (2012) deconvolution
method. We used the top 500 cell-specific CpGs as determined
above and the methylation profiles provided by Houseman et al.
for cell-sorted samples of adult blood. This method estimates a proportion of each cell type within each sample
(i.e., interpreted as the proportion of cells of that type in
each cord blood sample).

Statistical Analyses
Methylation Differences We used statistical methods developed by Houseman et al. (2012) to study methylation in this cohort. We defined a mixed effects model of DNAm percentage
for each CpG and cord blood sample, using gestational age and
gender as fixed effects and proportion of each cell type (estimated as above) as random effects. We used variance components analysis to determine the percentage of total variation
that is systematic (explained by both fixed and random effects)
and the percentage of systematic variation explained by cell
type proportions (explained by random effects). As part of this
analysis, we estimate model parameters that summarize the association between cell type proportion on gestational age as
described in Houseman et al. (2012).

Antenatal Steroid Application We obtained data on antenatal steroid use for 60 preterm infants in our cohort; 19 of those
infants were administered antenatal steroids. Their gestational
ages ranged from 30 to 36 weeks. We used logistic regression
to determine association between antenatal steroid administration and (a) gestational age, (b) infant gender, (c) granulocyte
proportion, and (d) CD4 T-cell proportion. The latter two were
estimated from DNAm measurements using the Houseman
et al. (2012) deconvolution method and then transformed
using an inverse logit transformation. All numerical covariates
were centered and scaled for this analysis. We then fit a linear
model regressing DNAm log ratio on antenatal steroid application and an interaction term between gestational age and
CD4 T-cell proportion as above. We used empirical Bayes
methods to shrink variance estimates across CpGs, and a
moderated t-test was performed to determine differentially
methylated CpGs, using the minfi package (Aryee et al.,
2014). CpGs were reported as differentially methylated at
1% false discovery rate.
RESULTS
Detailed statistical results are available (see Figures, Supplemental Digital Content 1, http://links.lww.com/NRES/A236).
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Changing Cell Type Proportions Across Gestational Age
After using the deconvolution method and performing cluster
analysis on the resulting cell type proportion estimates, we observed that samples segregated into two groups based on cell
type proportions (Figure 1A). One cluster is generally composed of granulocyte-rich samples; the other is generally composed of granulocyte-poor samples. There is also a significant
difference in gestational age between samples in the two clusters
(Figure 1B), with a mean of 39.0 (SD = 1.85) and 37.6 weeks
(SD = 2.59) on the granulocyte-rich and -poor samples, respectively (t-test: p = .000001; Wilcoxon rank sum test:
p = .000002), suggesting that differences in gestational
age are associated with blood cell type proportions. The
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cell type proportions of the cluster corresponding to later
gestational age is dominated by granulocytes, whereas the
cluster corresponding to earlier gestational age is characterized by diminished presence of granulocytes and increased
CD4 T cells, B cells, and NK cells (Figure 1A). Gestational
age variability differed within each of the two clusters; the
cluster corresponding to later gestational age had significantly
lower variance (SD = 1.85 vs. 2.59; F-test: p = .000006).
The regression analysis revealed the dynamics of cell type
proportions in cord blood (as estimated by DNAm in cell type
specific CpGs) when examined across a range of gestational
age groups (Table 1; Figure 1C and D; also see Figures, Supplemental Digital Content 2, http://links.lww.com/NRES/A237).

FIGURE 1. Differences in cell type proportions in cord blood are associated with gestational age. (A) Heatmap of blood cell type proportions estimated from
DNAm for 341 neonate cord blood samples. Hierarchical clustering is based on blood cell type proportions; colors under the tree are used to indicate
clustering of subjects into two groups (corresponding to granulocyte rich vs. granulocyte poor samples). (B) Gestational age distribution of subject
clusters determined by blood cell type proportions (granulocyte rich or granulocyte poor). Granulocyte rich samples (blue) are predominantly full term;
granulocyte poor samples (red) are predominantly preterm. (C) Proportion of granulocytes by gestational age. Marker types indicate subject gender, indicating
no significant difference in proportion due to gender. (D) Proportion of CD4 T cell by gestational age. Marker types indicate subject gender, indicating no
significant difference in proportion due to gender.
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TABLE 1. Association Between Gestational Age and Blood Cell
Type Proportions in Cord Blood
Cell type
Intercept
CD8 T
CD4 T
NK
B
Monocyte
Granulocyte

Estimate

Z-score

p

Adjusted p

−0.115
0.403
−1.016
−0.488
−0.519
0.04
1.747

−2.50
4.44
−7.09
−4.20
−5.83
0.56
7.51

.01
1e−05
0
3e−05
0
.58
0

.09
6e−05
0
.0002
0
1
0

Note. N = 341. NK = natural killer.

Granulocyte proportion varied most across gestational age;
the proportion nearly doubled from 32 to 40 weeks (Z-score = 7.5;
p = 6.08e−14; see Figure 1C). The second largest effect was for
CD4 T cells, where the proportion dropped by half from 32
to 40 weeks (Z-score = −7.08; p = 1.37e−12; see Figure 1D).
We observed smaller effects on B cells and NK cells, where the
proportion decreased across gestation. No significant changes
were observed for monocytes and CD8 T cells in this cohort.

Explaining Methylation Variability After Accounting
for Gestational Age
We sought to measure the amount of overall DNAm variability
that may be accounted for by differences in cell type proportions relative to differences in gestational age and gender. Following the methods described by Houseman et al. (2012), we
built a model including gestational age and gender as fixed effects, with estimated cell type proportion as a random effect,
as described in the Statistical Analysis. We obtained estimates
for total variation in methylation, along with an estimate of
systematic variation, which was partitioned into variation
explained by gestational age and gender and that explained
by cell type proportions. The percentage of total variation
explained by systematic variation was small (8.21%), but
the percentage of systematic variation explained by cell
type proportions was high (84.93%). This finding indicates
that, although systematic variation contributes modestly to
the total variation in methylation in this cohort, differences
in cell type proportions make up a significant percentage of
that variation. The percentages of DNAm variability explained by systematic variability and the percentages of systematic variability explained by cell type proportions are
similar to those reported by Houseman et al. (2012) in their
studies of adult cohorts.
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TABLE 2. Association Between Antenatal Steroid Application,
Gestational Age, Gender, and Cell Type Proportions in Cord
Blood
Term
Intercept
Gestational age (weeks)
Gender (male)
Granulocyte (proportion)
CD4 T cell (proportion)

Estimate

SE

Z-score

p

−0.775
−1.555
−0.646
−0.784
−1.002

0.485
0.475
0.749
0.499
0.494

−1.60
−3.27
−0.86
−1.57
−2.03

.11
.001
.39
.12
.04

Note. N = 60. SE = standard error.

lower CD4 T-cell concentration (Z-score = −2.03, p = .04).
On the basis of this observation, we regressed the methylation
log ratio for each CpG on antenatal steroid exposure, gestational age, and CD4 T-cell concentration. We compared two
models to determine the association between antenatal steroid
exposure and differences in DNAm: one model controlling for
gestational age and CD4 T-cell concentration and one not controlling for these.
When only considering antenatal steroid exposure in this
cohort, we found 127 CpGs that showed significant differences. On the other hand, only one CpG—in the promoter region of FRA10AC1—showed a significant difference in DNAm
when controlling for gestational age and CD4 T-cell concentration. We observed that subjects who received antenatal
steroids had consistently higher methylation at similar gestational age (Figure 2).

DISCUSSION
In this study, we observed that cell type proportions in the umbilical cord blood of term and preterm infants explain a

Potential Confounding by Cell Type Proportions and
Gestational Age
When we investigated a subsample of 19 infants exposed to
antenatal steroids, along with 41 infants for which we had record of no exposure to antenatal steroids, we found a strong
association between antenatal steroid exposure and both
early gestational age (Table 2; Z-score = −3.27, p = .001) and

FIGURE 2. DNAm percentage for 60 neonate cord blood samples for
a CpG in the promoter region of FRA10AC1 by gestational age. DNAm
changes in promoter region of FRA10AC1 are associated with gestational
age and antenatal steroid application. Points in red correspond to samples
where antenatal steroids were applied. Points in black are samples
where no antenatal steroids were applied. Point size is proportional to
estimated proportion of CD4 T cells.
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significant portion of systematic variation in this cohort after
accounting for gestational age in analyses of DNAm patterns;
and although systematic variation only explains a modest portion of total methylation variability, it is sufficient to affect findings of DNAm differences associated to phenotypes of interest.
Blood cell type methylation markers segregated the infant cohort by gestational age into two clusters: a cluster corresponding to later gestational age and a cluster corresponding to
earlier gestational age. The clusters were characterized by distinct cord blood cell type proportion profiles based on proportions of granulocytes, lymphocytes, and B cells. Some of our
findings are consistent with what is known about fetal cord
blood cell type proportions and its changes during gestation,
whereas others were unexpected.
The later gestational age cluster had significantly higher
numbers of granulocytes than did the earlier gestational age
cluster. This finding corresponds with the fact that normally
granulocytes increase rapidly in a fetus during the last trimester
(Maheshwari & Christensen, 2004). The number of circulating
granulocytes is around 10% of the leukocyte population at
14–16 weeks gestation and increases to 50%–60% by term. Previous research has also shown that preterm infants tend to have
a low proportion of granulocytes (Remington et al., 2001).
Lymphocyte proportion differed significantly between
the two clusters. CD4 T cells were more abundant in the cluster corresponding to earlier gestational age, which was unexpected because these cells should typically increase as
gestational age increases. Studies investigating CD4 T cells in
preterm infants showed lower counts compared to term infants (Chabra et al., 1998; Duijts et al., 2009). NK cells were
also more abundant in preterm infants than in term infants.
The literature has mixed findings for NK cell numbers during
gestation. NK cells have been found to increase over gestation
(Correa-Rocha et al., 2012; Pérez et al., 2007) and correlate
with gestational age (Ygberg & Nilsson, 2012). However,
Peoples et al. (2009) found increased NK cells in preterm infant cord blood compared to term infant cord blood.
B cells were more abundant in the early gestational age
cluster than in the late gestational age cluster, another unexpected finding. Correa-Rocha et al. (2012) found lower absolute counts of B cells in preterm infants, and there was a
positive correlation with gestational age and birth weight.
The total number of B cells exponentially increases over gestation and remains stable after 36 weeks (Thilaganathan et al.,
1993) and are abundant at birth (Ygberg & Nilsson, 2012).
There are a number of potential explanations for why CD4
T, NK, and B cells were more abundant in the earlier gestational age cluster than in the later gestational age cluster in this
sample. First, the proportion of granulocytes is significantly
lower in the cord blood of preterm infants, making selection
of other cell types during sampling more likely. The proportion of granulocytes compared to CD4 T, NK, and B cells
may be higher in later gestational age but may not affect the
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absolute value of CD4 T, NK, and B cells. Second, the higher
numbers of NK cells in the cord blood of the cluster associated
with earlier gestational age may be the result of inflammation. Research indicates that congenital infection in the second trimester is associated with an increased count of NK
cells (Remington et al., 2001). Infection and inflammation
are regarded as one of the most important and potentially
preventable causes of preterm birth (Burdet et al., 2014;
Kallapur, Presicce, Rueda, Jobe, & Chougnet, 2014; Romero
et al., 2014), but this biological mechanism would not explain the higher numbers of CD4 T and B cells. Third, a
number of exposures experienced by preterm infants can also
independently influence cord blood cell type proportions and
may explain some of our unexpected study findings, as well
the higher variability in blood cell type proportion in the cluster corresponding to earlier gestational age (Carreno et al.,
2011; Romero et al., 2014). For example, fetal exposure to maternal smoking is associated with normal to higher counts of T
cells (Remington et al., 2001).
Our analysis of antenatal steroid exposure demonstrates
how the relationship between cell type proportions and gestational age can confound analyses of an epigenetic response to
an exposure. The number of CpGs showing significant DNAm
associated with antenatal steroid application in this cohort
was reduced from 137 to a single CpG when controlling for
gestational age and blood cell type proportions. This suggests
that when the outcome under study, in this case, antenatal steroid exposure, correlates with gestational age and cell type
proportions—an analysis without proper controls results in
many false positives. Antenatal steroids are glucocorticoid steroids that have been found to be associated with changes in
DNAm on specific genomic sites in rat models (Ewald et al.,
2014). To the best of our knowledge, FRA10AC1 has not been
reported in the literature as a specific site affected by glucocorticoid steroids. Hypermethylation in the region FRA10A
C1 serves to counteract folate-sensitive fragility (Sarafidou
et al., 2004). Our observation of increased methylation in this
region associated with antenatal steroid application suggests
that further investigation of the association between hypermethylation and genomic instabilities associated with depletion of folic acid and the role of antenatal steroids in this
mechanism should be further explored.

Strengths and Limitations
The main strength of this study is that the BBC has a large sample size of preterm births, and a substantial number of umbilical cord blood samples were collected and analyzed using
the Illumina HumanMethylation27k BeadChip. The main limitation of this study is that the DMRs we used to identify individual blood cell types were developed using a reference
population of adult peripheral blood samples (see Houseman
et al., 2012). We used this methodology because there are currently no specific DMRs identified for umbilical cord blood.
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The lymphocyte subtypes in cord blood may have different
DNAm patterns because T-cell lineage epigenetically changes
at midgestation during fetal development (Basha, Surendran,
& Pichichero, 2014). It is possible that by utilizing the
Houseman et al. (2012) correction, we did not identify all of
the differences in cell type proportions that may occur across
gestational age. It will be important to replicate this study once
an umbilical cord blood correction is published.

Contributions to Nursing Science
Our study adds to nursing science by further elucidating the
complexities involved in performing epigenetic research.
Epigenetic researchers are still developing and refining
methodologies, such as the cell type proportion correction
we are suggesting that may be needed for the epigenetic
analysis of umbilical cord blood. Nurses are actively involved in epigenetic research on a variety of health issues
including pain, cardiovascular disease, childbirth, obesity,
and metabolic syndrome and will continue to participate
in the advancement of science. Understanding the latest advancements in this fast-developing field will be critical in
conducting and advancing epigenetic research. Nurses play
a key role in epigenetic research because of their unique insights into patients of all ages. This insight and rigorous research driven by multidisciplinary teams including nurses
will help move the evolving science of epigenetics forward.

Conclusion
Our analysis suggests that systematic variance accounts for
8.21% of total variation; of this, cell type proportions explains
84.93% of the systematic variation in DNAm of the umbilical
cord blood in this cohort. Researchers utilizing umbilical cord
blood to perform EWAS must consider cord blood cell type
proportion variability; however, the statistical methods currently used for studies based on adult whole blood are insufficient for this purpose. New statistical methods are needed to
account for the complexities of the cellular proportions of
cord blood—particularly preterm infant cord blood—which
would need to include the presence of certain cell types, such
as stem cells and nucleated red blood cells. EWAS have great
potential to improve our understanding of the impact of exposures on the fetal epigenome, but we must develop appropriate statistical methods and conduct carefully designed studies
in order to continue making significant progress.
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